Many pathways were perturbed in almost all the cancers, with p-value less than 0.01: IL-3 pathway (18), IL-2 pathway (17), TNF-alpha Pathway (17) EGFR1 pathway (16), TGF-beta receptor pathway (15), Alpha6 Beta4 Integrin pathway (14), and B Cell Receptor pathway (13). This evidence concerns the gene IL3 and cancer.